Issue 7, 2021, Issue in Progress
From the journal:

RSC Advances

Retraction: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3

Laura Fishera  

a Royal Society of Chemistry, Thomas Graham House, Science Park, Milton Road, Cambridge, UK
E-mail: advances-rsc@rsc.org

Abstract

Retraction of ‘MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3’ by Shiming Yang et al., RSC Adv., 2018, 8, 34973–34983, DOI: 10.1039/C8RA07055E.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D1RA90019F
Article type
Retraction
Submitted
12 Jan 2021
Accepted
12 Jan 2021
First published
20 Jan 2021
This article is Open Access
Creative Commons BY license

RSC Adv., 2021,11, 4166-4166

Permissions

Request permissions

Retraction: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3

L. Fisher, RSC Adv., 2021, 11, 4166 DOI: 10.1039/D1RA90019F

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements